"Stock traders believe the new strain's consequences will be short-lived and less damaging to the American economy. And the holiday season remains complicated by the new variant that is causing case spikes in the U.S., Europe and elsewhere. As a shortened week winds down, investors will be dealing with a heavy batch of economic data. The labor market recovery will also be slower without BBB, reducing employment by 750,000 jobs by the end of 2023. ---The Food and Drug Administration could authorize Covid-19 antiviral pills from Pfizer and Merck this week.

Source: The North Africa Journal December 22, 2021 23:02 UTC